Acral Melanoma in Skin of Color: Current Insights and Future Directions: A Narrative Review
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
Introduction: Acral lentiginous melanoma (ALM), a rare subtype, accounts for 2–3% of melanoma cases, primarily affecting the palms, soles, and nail beds and disproportionately affects people of color. This review focuses on clinical insights into ALM and its management, with a focus on race and ethnicity. Methods: A comprehensive literature search was conducted in public databases using the search term “acral melanoma,” and studies focusing on epidemiology, clinical presentation, and treatment outcomes of ALM in various racial and ethnic groups were reviewed. Results: Significant disparities in ALM outcomes exist across racial and ethnic groups, with African, Hispanic, and Asian individuals presenting with thicker, more advanced tumors at diagnosis. These populations encounter unique challenges, including limited access to dermatologic care, under-recognition of melanoma presentation in darker skin types, and socioeconomic barriers leading to delayed diagnosis and treatment. Surgical management may require specialized approaches, such as partial amputation for subungual melanomas. Additionally, there is uncertainty regarding the tumor immune microenvironment (TME) in ALM, with some studies suggesting that it might be less favorable, resulting in a lower response to immunotherapy. Conclusions: ALM affects diverse populations, and the impact of ethnic and racial origin on ALM biology is largely unknown. Addressing disparities in ALM outcomes among racial and ethnic groups is critical for improving patient care. Increased awareness of melanoma risk in individuals with darker skin can significantly impact early detection and treatment. Future research should focus on the genetic and biological factors contributing to morbidity and mortality in ALM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709030 · Cited by 2,246 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
Adjuvant pembrolizumab versus placebo in resected stage III melanoma
Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802357 · Cited by 1,906 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
Somatic Activation of KIT in Distinct Subtypes of Melanoma
Curtin, J. A., Busam, K., Pinkel, D., & Bastian, B. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2984 · Cited by 1,616
Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma
Patel, S. P., Othus, M., Chen, Y., Wright, G. P., Yost, K. J., Hyngstrom, J. R., Hu-Lieskovan, S., Lao, C. D., Fecher, L. A., Truong, T.-G., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211437 · Cited by 919 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005
Bradford, P. T., Goldstein, A. M., McMaster, M. L., & Tucker, M. A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2008.609 · Cited by 599
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
Blank, C. U., Lucas, M. W., Scolyer, R. A., van de Wiel, B. A., Menzies, A. M., Lopez-Yurda, M., Hoeijmakers, L. L., Saw, R. P. M., Lijnsvelt, J. M., Maher, N. G., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2402604 · Cited by 542
Andtbacka, R. H. I., Collichio, F., Harrington, K. J., Middleton, M. R., Downey, G., Ӧhrling, K., & Kaufman, H. L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0623-z · Cited by 455
Swetter, S. M., Thompson, J. A., Albertini, M. R., Barker, C. A., Baumgartner, J., Boland, G., Chmielowski, B., DiMaio, D., Durham, A., Fields, R. C., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0018 · Cited by 340
Acral lentiginous melanoma: a clinicoprognostic study of 126 cases: Prognosis of ALM
Phan, A., Touzet, S., Dalle, S., Ronger-Savlé, S., Balme, B., & Thomas, L. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07368.x · Cited by 285
Kirkwood, J. M., Del Vecchio, M., Weber, J., Hoeller, C., Grob, J.-J., Mohr, P., Loquai, C., Dutriaux, C., Chiarion-Sileni, V., Mackiewicz, J., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02583-2 · Cited by 239
Read, J., Wadt, K. A. W., & Hayward, N. K. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103150 · Cited by 231
Hereditary melanoma: Update on syndromes and management
Soura, E., Eliades, P. J., Shannon, K., Stratigos, A. J., & Tsao, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.038 · Cited by 230
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
Rabbie, R., Ferguson, P., Molina‐Aguilar, C., Adams, D. J., & Robles‐Espinoza, C. D. (2019) · The Journal of Pathology · doi:10.1002/path.5213 · Cited by 217
Torres-Cabala, C. A., Wang, W.-L., Trent, J., Yang, D., Chen, S., Galbincea, J., Kim, K. B., Woodman, S., Davies, M., Plaza, J. A., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.116 · Cited by 216
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
Newell, F., Wilmott, J. S., Johansson, P. A., Nones, K., Addala, V., Mukhopadhyay, P., Broit, N., Amato, C. M., Van Gulick, R., Kazakoff, S. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18988-3 · Cited by 186
Targeted Genomic Profiling of Acral Melanoma
Yeh, I., Jorgenson, E., Shen, L., Xu, M., North, J. P., Shain, A. H., Reuss, D., Wu, H., Robinson, W. A., Olshen, A., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz005 · Cited by 185
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
Mao, L., Qi, Z., Zhang, L., Guo, J., & Si, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680407 · Cited by 172
A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma
Zhang, C., Shen, H., Yang, T., Li, T., Liu, X., Wang, J., Liao, Z., Wei, J., Lu, J., Liu, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34877-3 · Cited by 168
The treatment of advanced melanoma: Current approaches and new challenges
Boutros, A., Croce, E., Ferrari, M., Gili, R., Massaro, G., Marconcini, R., Arecco, L., Tanda, E. T., & Spagnolo, F. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104276 · Cited by 160
Darmawan, C. C., Jo, G., Montenegro, S. E., Kwak, Y., Cheol, L., Cho, K. H., & Mun, J. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.01.081 · Cited by 158
Acral lentiginous melanoma: histopathological prognostic features of 121 cases
Phan, A., Touzet, S., Dalle, S., Ronger-Savle, S., Balme, B., & Thomas, L. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08031.x · Cited by 154
Qian, Y., Johannet, P., Sawyers, A., Yu, J., Osman, I., & Zhong, J. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.097 · Cited by 137
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104 · cited 1×
“The additive effect of socioeconomic status on survival in ethnic minorities with ALM was highlighted by a Brazilian study showing correlation of income with survival [10].”
KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma
Zebary, A., Omholt, K., Vassilaki, I., Höiom, V., Lindén, D., Viberg, L., Kanter‐Lewensohn, L., Johansson, C. H., & Hansson, J. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.07.013 · Cited by 101
Li, J., Smalley, I., Chen, Z., Wu, J.-Y., Phadke, M. S., Teer, J. K., Nguyen, T., Karreth, F. A., Koomen, J. M., Sarnaik, A. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3145 · Cited by 101
Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies
Mehnert, J. M., & Kluger, H. M. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0249-5 · Cited by 97
Alvarado, S. M., & Feng, H. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.041 · Cited by 93
Skin cancer awareness in suburban employees: A Hispanic perspective
Pipitone, M. A., Robinson, J. K., Camara, C., Chittineni, B., & Fisher, S. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120450 · Cited by 92
Sun, C., Sun, L., Jiang, K., Gao, D., Kang, X., Wang, C., Zhang, S., Huang, S., Qin, X. Y., Yan, L., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.017 · Cited by 85
Robinson, J. K., Joshi, K. M., Ortiz, S., & Kundu, R. V. (2011) · Psycho-Oncology · doi:10.1002/pon.1736 · Cited by 80 · cited 1×
“The funders had no role in study design, data collection and analysis, publication decisions, or manuscript preparation.”
Clinical guidelines for the recognition of melanoma of the foot and nail unit
Bristow, I., de Berker, D. A., Acland, K. M., Turner, R. J., & Bowling, J. C. (2010) · Journal of Foot and Ankle Research · doi:10.1186/1757-1146-3-25 · Cited by 80
Clinical Presentation and Staging of Melanoma
Ward, W. H., Lambreton, F., Goel, N., Yu, J. Q., & Farma, J. M. (2017) · Codon Publications eBooks · doi:10.15586/codon.cutaneousmelanoma.2017.ch6 · Cited by 80
Melanoma in skin of color: Part I. Epidemiology and clinical presentation
Brunsgaard, E. K., Wu, Y. P., & Grossman, D. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.04.056 · Cited by 73
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Bhave, P., Ahmed, T., Lo, S., Shoushtari, A. N., Zaremba, A., Versluis, J. M., Mangana, J., Weichenthal, M., Si, L., Lesimple, T., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004668 · Cited by 70
Translational pathology, genomics and the development of systemic therapies for acral melanoma
Chen, Y. A., Teer, J. K., Eroglu, Z., Wu, J.-Y., Koomen, J. M., Karreth, F. A., Messina, J. L., & Smalley, K. S. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.017 · Cited by 65
Lalloo, F. I., Kulkarni, A., Chau, C. H., Nielsen, M., Sheaff, M. T., Steele, J. P. C., van Doorn, R., Wadt, K., Hamill, M., Torr, B., et al. (2023) · European Journal of Human Genetics · doi:10.1038/s41431-023-01448-z · Cited by 59
de Castro, D. G., Fearfield, L. A., Nathan, P., Tanière, P., Wallace, A. J., Brown, E. R., Harwood, C. A., Marsden, J. R., & Whittaker, S. J. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12248 · Cited by 58
Acral melanoma: new insights into the immune and genomic landscape
Carvalho, L. A. D. C., Aguiar, F. C., Smalley, K. S. M., & Possik, P. A. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100947 · Cited by 56
Gumaste, P. V., Fleming, N. H., da Silva, I. P., Shapiro, R. L., Berman, R. S., Zhong, J., Osman, I., & Stein, J. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0172 · Cited by 55
Brunsgaard, E. K., Jensen, J., & Grossman, D. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.04.057 · Cited by 52
The genetic evolution of acral melanoma
Wang, M., Fukushima, S., Sheen, Y., Ramelyte, E., Cruz‐Pacheco, N., Shi, C., Liu, S., Banik, I., Aquino, J. D., Acosta, M. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50233-z · Cited by 50
Management of Acral and Mucosal Melanoma: Medical Oncology Perspective
Jung, S., & Johnson, D. B. (2022) · The Oncologist · doi:10.1093/oncolo/oyac091 · Cited by 47
Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management
Desai, A., Ugorji, R., & Khachemoune, A. (2017) · Clinical and Experimental Dermatology · doi:10.1111/ced.13323 · Cited by 45
Gui, J., Guo, Z., & Wu, D. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03532-2 · Cited by 41
Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA)
Nunes, L. F., Mendes, G. L. Q., & Koifman, R. J. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000476 · Cited by 40
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis
Kolla, A. M., Vitiello, G. A., Friedman, E. B., Sun, J. X., Potdar, A., Daou, H., Farrow, N. E., Farley, C. R., Vetto, J. T., Han, D., et al. (2021) · Cancer Control · doi:10.1177/10732748211053567 · Cited by 40
The tumor genetics of acral melanoma: What should a dermatologist know?
Tod, B., Schneider, J. W., Bowcock, A. M., Visser, W. I., & Kotze, M. J. (2020) · JAAD International · doi:10.1016/j.jdin.2020.07.004 · Cited by 39
Management of acral lentiginous melanoma: current updates and future directions
Dugan, M. M., Perez, M. C., Karapetyan, L., & Zager, J. S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1323933 · Cited by 39
Hong, J. W., Lee, S., Kim, D.-C., Kim, K., & Song, K. (2014) · Annals of Dermatology · doi:10.5021/ad.2014.26.2.195 · Cited by 38
Dai, B., Xu, C., Kong, Y.-Y., Yang, F., Shen, X.-X., Wang, L.-W., & Kong, J.-C. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.01.007 · Cited by 38
Reijers, I. L. M., Menzies, A. M., López‐Yurda, M., Versluis, J. M., Rozeman, E. A., Saw, R. P. M., van Houdt, W. J., Kapiteijn, E., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115141 · Cited by 38
Newsom, E. C., Lee, E. H., Rossi, A., Dusza, S. W., & Nehal, K. S. (2018) · Dermatologic Surgery · doi:10.1097/dss.0000000000001473 · Cited by 35
de Moura, N. G. R., Cordovil, I., & Ferreira, A. D. S. (2016) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(16)60233-9 · Cited by 33
Cheraghlou, S., Ugwu, N., & Girardi, M. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.4812 · Cited by 28
Multidisciplinary approach and treatment of acral and mucosal melanoma
Fortuna, A., & Amaral, T. M. S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1340408 · Cited by 27
Un-Fair Skin: racial disparities in acral melanoma research
Alicea, G. M., & Rebecca, V. W. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00443-8 · Cited by 26
Holman, D. M., King, J., White, A. L., Singh, S. D., & Lichtenfeld, J. L. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107692 · Cited by 26
Mechanisms of Action of Uncaria rhynchophylla Ethanolic Extract for Its Vasodilatory Effects
Loh, Y. C., Ch’ng, Y. S., Tan, C. S., Ahmad, M., Asmawi, M. Z., & Yam, M. F. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3804 · Cited by 25
KIT Mutation Incidence and Pattern of Melanoma in Central Europe
Doma, V., Barbai, T., Beleaua, M. A., Kovalszky, I., Rásó, E., & Tı́már, J. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00788-w · Cited by 25
Lenczowski, E., Tung‐Hahn, E., Higareda, J. A. S., McCormick, C. B., Markoff, T., Arffa, M., Poon, E., Lee, K. K., & Alam, M. (2017) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2017.10.005 · Cited by 23
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan
Hida, T., Idogawa, M., Kato, J., Kiniwa, Y., Horimoto, K., Sato, S., Sawada, M., Tange, S., Okura, M., Okuyama, R., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70360 · Cited by 19
Sun Protection Education for Diverse Audiences: Need for Skin Cancer Pictures
Guevara, Y., Gaber, R., Clayman, M. L., Gordon, E. J., Friedewald, J. J., & Robinson, J. K. (2014) · Journal of Cancer Education · doi:10.1007/s13187-014-0661-7 · Cited by 17
Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?
Walker, M. E., Han, G., Gabrick, K. S., Kanouzi, J., Lo, Y., Galan, A., Clune, J. E., Narayan, D., Ariyan, S., & Han, D. (2020) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002698 · Cited by 16
Diagnosis and Management of Acral Pigmented Lesions
Ingrassia, J. P., Stein, J., Levine, A., & Liebman, T. N. (2023) · Dermatologic Surgery · doi:10.1097/dss.0000000000003891 · Cited by 16
Lee, A. Y., Friedman, E. B., Sun, J. X., Potdar, A., Daou, H., Farrow, N. E., Farley, C. R., Vetto, J. T., Han, D., Tariq, M., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08708-y · Cited by 14
Kailas, A., Botwin, A. L., Pritchett, E., Jackson‐Richards, D., Lewis, S., Sadhwani, D., Desai, S. R., & Taylor, S. C. (2017) · PubMed · Cited by 13
Dermoscopic patterns of acral melanocytic lesions in skin of color.
Tan, A., & Stein, J. (2019) · PubMed · Cited by 13
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study
Giasson-Gariépy, K., Potvin, S., Ghabrash, M. F., Bruneau, J., & Jutras‐Aswad, D. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.03.025 · Cited by 12
Grewal, S. K., Reddy, V. D., Tomz, A., Lester, J., Linos, E., & Lee, P. K. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.121 · Cited by 12
Li, S., Sheng, X., Si, L., Cui, C., Kong, Y., Mao, L., Lian, B., Tang, B., Yan, X., Wang, X., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6256-x · Cited by 11
Elad, V. M., Anton, T., Ganios, N. C., & Rebecca, V. W. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13090 · Cited by 10
Genomic characterization reveals distinct mutational landscape of acral melanoma in East Asian
Zhang, F., Wu, X., Jiao, T., Du, H., Guo, Q., Cui, C., Chi, Z., Sheng, X., Jiang, D., Zhang, Y., et al. (2025) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.12.018 · Cited by 10
Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals
Gao, H., Tsai, W., Perng, C., Wang, W., & Chiang, C. (2018) · European Journal of Dermatology · doi:10.1684/ejd.2018.3359 · Cited by 9
Recent advancements in the diagnosis and treatment of acral melanoma
Alhaskawi, A., Ezzi, S. H. A., Dong, Y., Zhou, H., Wang, Z., Lai, J., Yao, C., Kota, V. G., Abdulla, M. H. A. H., & Lü, H. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300221 · Cited by 9
Natarelli, N., Hanlon, K., Chen, W., Grichnik, J. M., Zager, J. S., & Correa‐Selm, L. (2023) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23647 · Cited by 6
Ansbro, B., & Riley, J. M. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03167-x · Cited by 5
Raj, R. C., & Patil, R. (2015) · Indian Journal of Dermatology · doi:10.4103/0019-5154.152585 · Cited by 4
Fast ultrasound is fine, but accuracy is everything
Rea, G., & Cipriani, C. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.04.019 · Cited by 3
Community-engaged education and evaluation of an acral lentiginous melanoma awareness initiative
Jaklitsch, E. L., Lin, A. J., & James, A. J. (2024) · Journal of the National Medical Association · doi:10.1016/j.jnma.2024.01.021 · Cited by 2
2015 Legislative Session--A Recap of AMS Efforts.
Penn, C. L. (2015) · PubMed · Cited by 1
Lucas, M. W., Rozeman, E. A., Versluis, J. M., Menzies, A. M., Eriksson, H., van de Wiel, B. A., Scolyer, R. A., van Thienen, J. V., Mallo, H. A., Gonzalez, M., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.09.2230 · Cited by 1
Cited by
Brar, G., Dhaliwal, A., Brar, A. S., Sreedevi, M., Ahmadi, Y., Irfan, M., Golbari, R., Zumárraga, D., Yateem, D., Lysak, Y., et al. (2025) · Cureus · doi:10.7759/cureus.81109 · Cited by 22
Histopathological Subtypes of Cutaneous Melanoma: Prognostic and Molecular Implications
Qasim, H., Shugaer, M. A., Khattab, K., Leoni, M. L. G., & Varrassi, G. (2025) · Cureus · doi:10.7759/cureus.90670 · Cited by 10
Fernández-Coto, D. L., Ayala, M., Alonso-Bastida, R., Palmqvist, A., García, M. F., Balderas-López, S. F., Oskolás, H., Christersson, L., Fülöp, L., Szigeti, B., et al. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101620 · Cited by 2
Nadelmann, E. R., Singh, A. K., Abbruzzese, M., Adeuyan, O. O., Kenchappa, D., Kovrizhkin, K., Lightman, M., Samouha, A., Tao, K. L., Yun, J., et al. (2025) · Cancers · doi:10.3390/cancers17152458 · Cited by 2
Self-citationTaylor, M. A., Beach, L., McGrath, J., Shelton, E. M., Sharma, D., & Wysong, A. S. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.12.033 · Cited by 1
Metadata
- Authors
- Nadelmann, E., Singh, A., Abbruzzese, M., Adeuyan, O., Kenchappa, D., Kovrizhkin, K., Lightman, M., Samouha, A., Tao, K., Yun, J., Zhu, T., McLellan, B., & Saenger, Y.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Saenger, Yvonne
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2025-01-30
- Volume
- 17
- Issue
- 3
- Pages
- 468
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC11816340
- OpenAlex
- W4406968808
- Cited by
- 20
- References
- 88
- Citations by year
- 2026: 10 · 2025: 10
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-01-30)
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01 CA260375)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- acral lentiginous melanoma, skin of color, racial and ethnic disparities, subungual melanoma, delayed diagnosis, tumor immune microenvironment, immunotherapy response, partial amputation, melanoma epidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.